| Literature DB >> 34614404 |
Samuel Mon-Wei Yu1, John Cijiang He2.
Abstract
In a new study, Zhu et al. (2021) show that mitigating dysbiosis by the probiotic L. casei Zhang reduces kidney inflammation via restoring short-chain fatty acid-producing gut microbiome and nicotinamide metabolism. These findings shed light on the underlying mechanisms of probiotics in treating human kidney diseases. Published by Elsevier Inc.Entities:
Mesh:
Year: 2021 PMID: 34614404 PMCID: PMC8994854 DOI: 10.1016/j.cmet.2021.08.019
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287